PGP and cancer: It has been shown that a combination therapy protocol that combines a front-line chemotherapy that is a Pgp substrate together with a CA XII inhibitor blocks the Pgp-mediated resistance mechanism restores the efficacy of the chemotherapy in resistant cancer cells.